{"id":"https://openalex.org/W2009724412","doi":"https://doi.org/10.1016/s0149-2918(00)80005-3","title":"Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis","display_name":"Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis","alternate_titles":[],"publication_year":1999,"publication_date":"1999-09-01","ids":{"openalex":"https://openalex.org/W2009724412","doi":"https://doi.org/10.1016/s0149-2918(00)80005-3","mag":"2009724412","pmid":"https://pubmed.ncbi.nlm.nih.gov/10509845"},"language":"en","primary_location":{"id":"doi:10.1016/s0149-2918(00)80005-3","doi":"https://doi.org/10.1016/s0149-2918(00)80005-3","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0149-2918(00)80005-3","pdf_url":"https://doi.org/10.1016/s0149-2918(00)80005-3","source":{"id":"https://openalex.org/S185879095","display_name":"Clinical Therapeutics","issn_l":"0149-2918","issn":["0149-2918","1879-114X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2009724412"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/s0149-2918(00)80005-3","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019516873","display_name":"Marvin M. Goldenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320796813","display_name":"Mount Sinai Health System","ror":"https://ror.org/04kfn4587","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1320796813"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Marvin M. Goldenberg","raw_affiliation_strings":["Mount Sinai NYU Health, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mount Sinai NYU Health, New York, New York, USA","institution_ids":["https://openalex.org/I1320796813"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5019516873"],"corresponding_institution_ids":["https://openalex.org/I1320796813"],"apc_list":{"value":4240,"currency":"USD","value_usd":4240},"apc_paid":{"value":4240,"currency":"USD","value_usd":4240},"fwci":0.9154,"has_fulltext":true,"cited_by_count":168,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.66847826,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"21","issue":"9","first_page":"1497","last_page":"1513"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10105","display_name":"Osteoarthritis Treatment and Mechanisms","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":1.0},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.9169999957084656},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.8569999933242798},{"id":"https://openalex.org/keywords/osteoarthritis","display_name":"osteoarthritis","score":1.0},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9229999780654907},{"id":"https://openalex.org/keywords/cox-1","display_name":"cyclooxygenase-1","score":0.6930000185966492},{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.9269999861717224},{"id":"https://openalex.org/keywords/prostaglandins","display_name":"prostaglandins","score":0.7269999980926514},{"id":"https://openalex.org/keywords/gastric-ulcer","display_name":"gastric ulcer","score":0.7080000042915344},{"id":"https://openalex.org/keywords/diclofenac","display_name":"diclofenac","score":0.8619999885559082},{"id":"https://openalex.org/keywords/naproxen","display_name":"naproxen","score":0.9950000047683716},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.625},{"id":"https://openalex.org/keywords/analgesic-efficacy","display_name":"analgesic efficacy","score":0.7099999785423279}],"concepts":[{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.9799256324768066},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9347962737083435},{"id":"https://openalex.org/C2779826273","wikidata":"https://www.wikidata.org/wiki/Q244408","display_name":"Diclofenac","level":2,"score":0.8706725835800171},{"id":"https://openalex.org/C2776164576","wikidata":"https://www.wikidata.org/wiki/Q62736","display_name":"Osteoarthritis","level":3,"score":0.7728097438812256},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.7659817934036255},{"id":"https://openalex.org/C2778115740","wikidata":"https://www.wikidata.org/wiki/Q1215575","display_name":"Naproxen","level":3,"score":0.7568498253822327},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.7257577180862427},{"id":"https://openalex.org/C2778582115","wikidata":"https://www.wikidata.org/wiki/Q411412","display_name":"Rofecoxib","level":4,"score":0.6771217584609985},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.5730546116828918},{"id":"https://openalex.org/C2779528491","wikidata":"https://www.wikidata.org/wiki/Q347613","display_name":"Valdecoxib","level":5,"score":0.5685372352600098},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5550692677497864},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.5354528427124023},{"id":"https://openalex.org/C2777456732","wikidata":"https://www.wikidata.org/wiki/Q425207","display_name":"Nabumetone","level":3,"score":0.5303770899772644},{"id":"https://openalex.org/C2777031258","wikidata":"https://www.wikidata.org/wiki/Q377458","display_name":"COX-2 inhibitor","level":4,"score":0.501288652420044},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4362225830554962},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4182606041431427},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.39953044056892395},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.15489399433135986},{"id":"https://openalex.org/C2778484676","wikidata":"https://www.wikidata.org/wiki/Q20707196","display_name":"Nonsteroidal","level":2,"score":0.08898589015007019},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000068579","descriptor_name":"Celecoxib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010003","descriptor_name":"Osteoarthritis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011451","descriptor_name":"Prostaglandin-Endoperoxide Synthases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0149-2918(00)80005-3","doi":"https://doi.org/10.1016/s0149-2918(00)80005-3","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0149-2918(00)80005-3","pdf_url":"https://doi.org/10.1016/s0149-2918(00)80005-3","source":{"id":"https://openalex.org/S185879095","display_name":"Clinical Therapeutics","issn_l":"0149-2918","issn":["0149-2918","1879-114X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Therapeutics","raw_type":"journal-article"},{"id":"pmid:10509845","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10509845","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical therapeutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/s0149-2918(00)80005-3","doi":"https://doi.org/10.1016/s0149-2918(00)80005-3","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0149-2918(00)80005-3","pdf_url":"https://doi.org/10.1016/s0149-2918(00)80005-3","source":{"id":"https://openalex.org/S185879095","display_name":"Clinical Therapeutics","issn_l":"0149-2918","issn":["0149-2918","1879-114X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2009724412.pdf","grobid_xml":"https://content.openalex.org/works/W2009724412.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W1485442945","https://openalex.org/W1488935046","https://openalex.org/W1494920110","https://openalex.org/W1536031017","https://openalex.org/W1544157645","https://openalex.org/W1587123510","https://openalex.org/W1853539513","https://openalex.org/W1921815852","https://openalex.org/W1928411162","https://openalex.org/W1961470626","https://openalex.org/W1964533656","https://openalex.org/W1997208118","https://openalex.org/W1997364548","https://openalex.org/W2003599597","https://openalex.org/W2003897562","https://openalex.org/W2005424427","https://openalex.org/W2008574207","https://openalex.org/W2015371826","https://openalex.org/W2020563114","https://openalex.org/W2030850720","https://openalex.org/W2033255776","https://openalex.org/W2033448452","https://openalex.org/W2033498682","https://openalex.org/W2046501054","https://openalex.org/W2049021766","https://openalex.org/W2077459776","https://openalex.org/W2082095075","https://openalex.org/W2083748640","https://openalex.org/W2086996966","https://openalex.org/W2094752831","https://openalex.org/W2113745276","https://openalex.org/W2115350007","https://openalex.org/W2115578029","https://openalex.org/W2117227343","https://openalex.org/W2132579331","https://openalex.org/W2134732424","https://openalex.org/W2142750917","https://openalex.org/W2146605723","https://openalex.org/W2158686638","https://openalex.org/W2159973565","https://openalex.org/W2166592633","https://openalex.org/W2172699068","https://openalex.org/W2266185506","https://openalex.org/W2317888114","https://openalex.org/W2412481048","https://openalex.org/W2800526221","https://openalex.org/W3103908430","https://openalex.org/W4250528986"],"related_works":["https://openalex.org/W2133848761","https://openalex.org/W2056985247","https://openalex.org/W2323603075","https://openalex.org/W2158811477","https://openalex.org/W2039149640","https://openalex.org/W2412403023","https://openalex.org/W175209219","https://openalex.org/W2163756514","https://openalex.org/W2430771846","https://openalex.org/W1979211090"],"abstract_inverted_index":{"Nonsteroidal":[0],"anti-inflammatory":[1,262],"drugs":[2],"(NSAIDs)":[3],"are":[4],"among":[5],"the":[6,21,33,50,78,105,137,158,188,191,200,206,221,230,235],"most":[7,241],"frequently":[8,198],"prescribed":[9],"drugs,":[10],"despite":[11],"their":[12],"well-established":[13],"association":[14],"with":[15,113,135,217,292,308],"gastroduodenal":[16,193],"injury.":[17],"Recent":[18],"discovery":[19],"of":[20,32,35,115,120,129,162,185,190,223,245],"cyclooxygenase":[22],"(COX)":[23],"isoenzymes":[24,75],"COX-1":[25,37],"and":[26,67,101,110,122,132,149,160,166,219,255,263,266,314],"COX-2":[27,57,96],"has":[28,125,258,267],"improved":[29],"our":[30],"knowledge":[31],"action":[34],"NSAIDs.":[36,281],"is":[38,58,312],"continuously":[39],"expressed":[40],"in":[41,54,60,199,205,229,234,247,306],"almost":[42],"all":[43],"tissues,":[44],"where":[45],"it":[46,283],"converts":[47],"arachidonate":[48],"to":[49,155,175,295,316],"prostaglandins":[51],"(PGs)":[52],"important":[53],"homeostatic":[55],"function;":[56],"present":[59],"immune":[61],"cells,":[62,66],"blood":[63],"vessel":[64],"endothelial":[65],"synovial":[68],"fibroblasts.":[69],"Classic":[70],"NSAIDs":[71],"inhibit":[72],"both":[73],"COX":[74],"by":[76,83],"occupying":[77],"cyclooxygenase-active":[79],"site,":[80],"preventing":[81],"access":[82],"arachidonic":[84],"acid.":[85],"In":[86,117,141,168,210],"theory,":[87],"a":[88,211],"drug":[89],"such":[90],"as":[91,177,180],"celecoxib":[92,124,144,172,207,216,236,246],"that":[93],"selectively":[94],"inhibited":[95],"might":[97],"block":[98],"inflammation,":[99],"pain,":[100,123],"fever":[102],"while":[103],"reducing":[104],"side":[106],"effects":[107,244,289],"(gastric":[108],"erosions":[109],"ulcers)":[111],"associated":[112],"inhibition":[114],"COX-1.":[116],"animal":[118],"models":[119],"inflammation":[121,133],"shown":[126,259],"marked":[127],"suppression":[128],"PG":[130],"production":[131],"compared":[134],"indomethacin,":[136],"standard":[138],"COX-1/COX-2":[139],"inhibitor.":[140],"clinical":[142,248],"trials,":[143],"dosed":[145],"at":[146,187],"100,":[147],"200,":[148],"400":[150],"mg":[151],"BID":[152],"was":[153,173,226],"found":[154,174],"significantly":[156,196,227],"reduce":[157],"signs":[159],"symptoms":[161],"rheumatoid":[163],"arthritis":[164],"(RA)":[165],"osteoarthritis.":[167],"one":[169],"RA":[170],"study,":[171,192],"be":[176,317],"clinically":[178],"effective":[179],"diclofenac":[181,201],"after":[182],"24":[183],"weeks":[184],"treatment;":[186],"end":[189],"ulcers":[194],"occurred":[195],"more":[197],"group":[202,208,232],"(15%)":[203],"than":[204,233,277],"(4%).":[209],"1-week":[212],"endoscopy":[213],"study":[214],"comparing":[215],"naproxen":[218,231],"placebo,":[220],"incidence":[222],"gastric":[224],"erosions/ulcers":[225],"greater":[228],"or":[237,275,290,304],"placebo":[238],"group.":[239],"The":[240],"common":[242],"adverse":[243,288,298],"studies":[249],"were":[250],"headache,":[251],"diarrhea,":[252],"abdominal":[253],"discomfort,":[254],"dizziness.":[256],"Celecoxib":[257],"significant":[260],"equivalent":[261],"analgesic":[264],"efficacy":[265],"produced":[268],"less":[269],"endoscopically":[270],"apparent":[271],"gastrointestinal":[272],"(GI)":[273],"ulceration":[274],"erosion":[276],"have":[278,285],"3":[279],"classic":[280],"Whether":[282],"will":[284],"long-term":[286],"GI":[287,302],"interact":[291],"other":[293,309],"medications":[294],"cause":[296],"serious":[297],"responses":[299],"(eg,":[300],"increased":[301],"bleeding":[303],"rash":[305],"conjunction":[307],"sulfonamide-like":[310],"drugs)":[311],"unknown":[313],"remains":[315],"established.":[318]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2009724412","counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
